123 Main Street, New York, NY 10001

Top Navigation with Mega Menu

Co-Dx™ closes acquisition of two biotech companies

Finalizing agreements with Idaho Molecular and Advanced Conceptions.

Co-Dx has finalized the acquisition under which Idaho Molecular and Advanced Conceptions become its wholly owned subsidiaries. The acquisition follows collaborative work with the two biotech companies on the development of the Co-Dx PCR Home™ Testing Platform.

Read the article here:

https://www.nsmedicaldevices.com/news/co-diagnostics-acquires-two-diagnostics-firms/